Decreased expression of the carboxyl terminus of heat shock cognate 70 interacting protein in human gastric cancer and its clinical significance

Oncology Reports

Volumn 28, Issue 4, 2012, Pages 1392-1398

  Gan, Lei ^a   Liu, Dong Bo ^a   Lu, Hai Feng ^b   Long, Guo Xian ^a   Mei, Q I ^a   Hu, Guang Yuan ^a   Qiu, Hong ^a   Hu, Guo Qing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Carboxyl terminus of heat shock cognate 70 interacting protein; Clinicopathological characteristics; Gastric cancer

Indexed keywords

CARBOXYL TERMINUS OF HEAT SHOCK COGNATE 70 INTERACTING PROTEIN; MESSENGER RNA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; REFERENCE VALUES; STOMACH NEOPLASMS; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 84866452745     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1957     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
3. Vogiatzi P, Vindigni C, Roviello F, Renieri A and Giordano A: Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Physiol 211: 287-295, 2007.
4. Sasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H and Tahara E: Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 35: 111-115, 2000.
5. Lee JH, Han SU, Cho H, et al: A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene 19: 4947-4953, 2000.
6. Allgayer H, Babic R, Gruetzner KU, Tarabichi A, Schildberg FW and Heiss MM: c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. J Clin Oncol 18: 2201-2209, 2000.
7. Drebber U, Baldus SE, Nolden B, et al: The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation. Oncol Rep 19: 1477-1483, 2008.
8. Shiao YH, Rugge M, Correa P, Lehmann HP and Scheer WD: p53 alteration in gastric precancerous lesions. Am J Pathol 144: 511-517, 1994.
9. Ebert MP, Yu J, Hoffmann J, et al: Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol 21: 1708-1714, 2003.
10. Wen YG, Wang Q, Zhou CZ, Qiu GQ, Peng ZH and Tang HM: Mutation analysis of tumor suppressor gene PTEN in patients with gastric carcinomas and its impact on PI3K/AKT pathway. Oncol Rep 24: 89-95, 2010.
11. Sakata M, Kitamura YH, Sakuraba K, et al: Methylation of HACE1 in gastric carcinoma. Anticancer Res 29: 2231-2233, 2009.
12. Wu F, Shirahata A, Sakuraba K, et al: Down-regulation of EGFL8: a novel biomarker for advanced gastric cancer. Anticancer Res 31: 3377-3380, 2011.
13. Paoletti X, Oba K, Burzykowski T, et al: Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303: 1729-1737, 2010.
14. Crew KD and Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362, 2006.
15. Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS and Rabkin CS: Age-specific trends in incidence of non-cardia gastric cancer in US adults. JAMA 303: 1723-1728, 2010.
16. Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY and Patterson C: Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 19: 4535-4545, 1999.
17. Lamb JR, Tugendreich S and Hieter P: Tetratricopeptide repeat interactions: to TPR or not to TPR? Trends Biochem Sci 20: 257-259, 1995.
18. Murata S, Minami Y, Minami M, Chiba T and Tanaka K: CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep 2: 1133-1138, 2001.
19. Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Hohfeld J and Patterson C: The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 3: 93-96, 2001.
20. Meacham GC, Patterson C, Zhang W, Younger JM and Cyr DM: The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat Cell Biol 3: 100-105, 2001.
21. Kajiro M, Hirota R, Nakajima Y, et al: The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nat Cell Biol 11: 312-319, 2009.
22. Xu T, Zhou Q, Zhou J, et al: Carboxyl terminus of Hsp70-interacting protein (CHIP) contributes to human glioma oncogenesis. Cancer Sci 102: 959-966, 2011.
23. Jang KW, Lee JE, Kim SY, et al: The C-terminus of Hsp70-interacting protein promotes Met receptor degradation. J Thorac Oncol 6: 679-687, 2011.
24. Lakshmanan M, Bughani U, Duraisamy S, Diwan M, Dastidar S and Ray A: Molecular targeting of E3 ligases - a therapeutic approach for cancer. Expert Opin Ther Targets 12: 855-870, 2008.
25. Zhou P, Fernandes N, Dodge IL, et al: ErbB2 degradation mediated by the co-chaperone protein CHIP. J Biol Chem 278: 13829-13837, 2003.
26. McDonough H and Patterson C: CHIP: a link between the chaperone and proteasome systems. Cell Stress Chaperones 8: 303-308, 2003.
27. Fan M, Park A and Nephew KP: CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-α. Mol Endocrinol 19: 2901-2914, 2005.
28. Esser C, Scheffner M and Hohfeld J: The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation. J Biol Chem 280: 27443-27448, 2005.
29. McDonough H, Charles PC, Hilliard EG, et al: Stress-dependent Daxx-CHIP interaction suppresses the p53 apoptotic program. J Biol Chem 284: 20649-20659, 2009.
30. Huang H and Tindall DJ: Dynamic FoxO transcription factors. J Cell Sci 120: 2479-2487, 2007.
31. Li F, Xie P, Fan Y, et al: C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitin-mediated degradation of FoxO1. J Biol Chem 284: 20090-20098, 2009.
32. Luo W, Zhong J, Chang R, Hu H, Pandey A and Semenza G: Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1α but not HIF-2α. J Biol Chem 285: 3651-3663, 2010.